• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The activity of cefotaxime and desacetylcefotaxime against Bacteroides species compared to 7-methoxy cephems and other anti-anaerobe drugs.

作者信息

Jones R N

出版信息

J Antimicrob Chemother. 1984 Sep;14 Suppl B:39-43. doi: 10.1093/jac/14.suppl_b.39.

DOI:10.1093/jac/14.suppl_b.39
PMID:6094461
Abstract

The combination of cefotaxime and desacetylcefotaxime was tested against 83 Bacteroides strains (seven species) isolated from several hospitals. The combination greatly enhanced the anti-anaerobic spectrum of cefotaxime: 79.7% of tested strains were synergistically killed by the combination. Although the combination appears clinically efficacious, it is only comparable to cefoxitin and still less active than clindamycin, chloramphenicol and metronidazole.

摘要

相似文献

1
The activity of cefotaxime and desacetylcefotaxime against Bacteroides species compared to 7-methoxy cephems and other anti-anaerobe drugs.
J Antimicrob Chemother. 1984 Sep;14 Suppl B:39-43. doi: 10.1093/jac/14.suppl_b.39.
2
The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
Diagn Microbiol Infect Dis. 1984 Jun;2(3 Suppl):37S-46S.
3
Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.
Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S374-8. doi: 10.1093/clinids/4.supplement_2.s374.
4
Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis.头孢噻肟单独及与去乙酰头孢噻肟联合应用对脆弱拟杆菌的有效性。
Diagn Microbiol Infect Dis. 1989 Jan-Feb;12(1):39-43. doi: 10.1016/0732-8893(89)90044-8.
5
The synergistic effect of cefotaxime and desacetylcefotaxime against clinical isolates of anaerobic bacteria.
Drugs. 1988;35 Suppl 2:45-50. doi: 10.2165/00003495-198800352-00011.
6
Comparative in vitro activity of cefoxitin, cefotaxime alone, and in combination with desacetylcefotaxime against the Bacteroides species.
Diagn Microbiol Infect Dis. 1989 Jan-Feb;12(1):33-7. doi: 10.1016/0732-8893(89)90043-6.
7
In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
Diagn Microbiol Infect Dis. 1984 Jun;2(3 Suppl):47S-53S.
8
Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
Diagn Microbiol Infect Dis. 1984 Jun;2(3 Suppl):21S-31S.
9
Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.
Diagn Microbiol Infect Dis. 1989 Jan-Feb;12(1):45-50. doi: 10.1016/0732-8893(89)90045-x.
10
[In vitro evaluation of the activity and interactions of cefotaxime and its metabolite desacetylcefotaxime against strains of enterobacteria, staphylococci and Bacteroides fragilis isolated from hospital infections].
G Ital Chemioter. 1989 Jan-Dec;36(1-3):57-64.

引用本文的文献

1
The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years.头孢噻肟的抗菌活性：涵盖15年的多国医院分离株比较调查
Infection. 1994;22 Suppl 3:S152-60. doi: 10.1007/BF01782700.
2
Synergistic interaction between ofloxacin and cefotaxime against common clinical pathogens.
Infection. 1995 May-Jun;23(3):154-61. doi: 10.1007/BF01793856.
3
Microbiological investigation of cephalosporins.头孢菌素的微生物学研究。
Drugs. 1987;34 Suppl 2:23-43. doi: 10.2165/00003495-198700342-00005.
4
In vitro activity of Ro 24-6392, a novel ester-linked co-drug combining ciprofloxacin and desacetylcefotaxime.
Eur J Clin Microbiol Infect Dis. 1990 Jun;9(6):435-8. doi: 10.1007/BF01979478.
5
Cefotaxime. An update of its pharmacology and therapeutic use.头孢噻肟。其药理学与治疗应用的最新进展。
Drugs. 1990 Oct;40(4):608-51. doi: 10.2165/00003495-199040040-00008.